SCHEMBL11212262

SCHEMBL11212262

[CH2]Sc1nnc(O)c(=O)n1CCCC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
USP2 O75604 2/20 0.35
ALDH1A1 P00352 9/20 0.35
KDM4E B2RXH2 4/20 0.35
POLB P06746 3/20 0.35
MAPT P10636 3/20 0.34
HPGD P15428 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
LMNA P02545 3/20 0.33
GAA P10253 2/20 0.33
RGS4 P49798 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP2C19 P33261 2/20 0.33
RECQL P46063 2/20 0.33
CYP2C9 P11712 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11216028 0.90 SMN1; SMN2 (0.38) USP2ALDH1A1KDM4EPOLBHPGD
SCHEMBL11212263 0.86 SMN1; SMN2 (0.41) TDP1L3MBTL1USP2ALDH1A1KDM4E
SCHEMBL11691585 0.70 MAPT (0.35) USP2ALDH1A1MAPTHPGDSMN1; SMN2
SCHEMBL11312854 0.68 SMN1; SMN2 (0.55) ALDH1A1KDM4EPOLBMAPTSMN1; SMN2
SCHEMBL10361075 0.63 ALDH1A1 (0.31) ALDH1A1
SCHEMBL11371877 0.62 USP2 (0.43) L3MBTL1USP2ALDH1A1HPGDSMN1; SMN2
SCHEMBL11362453 0.61 SRC (0.34) L3MBTL1KDM4EPOLBMAPK1HSD17B10
SCHEMBL11687235 0.61 HTT (0.52) USP2ALDH1A1POLBMAPTHPGD
SCHEMBL838929 0.60 RGS4 (0.58) TDP1L3MBTL1MAPTGAARGS4
SCHEMBL11376315 0.59 SMN1; SMN2 (0.52) L3MBTL1USP2ALDH1A1POLBHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4329454-A Cephalosporin compounds ELI LILLY AND COMPANY (US) 1982-05-11 US disclosed
EP-0002605-B1 CEPHALOSPORIN COMPOUNDS AND FORMULATIONS CONTAINING THEM FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS AND THE PREPARATION OF THE CEPHALOSPORIN COMPOUNDS ELI LILLY AND COMPANY (US) 1981-12-30 EP disclosed
US-4200745-A 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins ELI LILLY AND COMPANY (US) 1980-04-29 US disclosed
EP-0002605-A1 Cephalosporin compounds and formulations containing them for use in the treatment of bacterial infections and the preparation of the cephalosporin compounds ELI LILLY AND COMPANY (US) 1979-06-27 EP disclosed
US-4061861-A ANTIBIOTIC ELI LILLY AND COMPANY (US) 1977-12-06 US disclosed
US-4048161-A ANTIBIOTICS ELI LILLY AND COMPANY (US) 1977-09-13 US disclosed